US 10995336
Serpina1 iRNA compositions and methods of use thereof
granted A61PA61P1/16A61P35/00
Quick answer
US patent 10995336 (Serpina1 iRNA compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue May 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 41
- CPC classes
- A61P, A61P1/16, A61P35/00, A61P43/00